Gland Pharma Ltd updates on US FDA Inspection at Dundigal Facility, Hyderabad
Gland Pharma Ltd has announced about the Pre-Market Inspection covering US FDA's Quality System / Current Good Manufacturing Practice regulations for Medical Devices i.e., 21 CFR Part 820 at Dundigal Facility at Hyderabad.
Source: equitybulls.com